Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$271.54 - $344.06 $8,417 - $10,665
-31 Reduced 25.83%
89 $30,000
Q1 2023

May 09, 2023

SELL
$220.43 - $278.69 $220 - $278
-1 Reduced 0.83%
120 $33,000
Q4 2022

May 09, 2023

BUY
$151.88 - $228.5 $18,377 - $27,648
121 New
121 $26,000
Q1 2021

May 13, 2021

SELL
$175.6 - $291.43 $28,447 - $47,211
-162 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$174.98 - $272.83 $31,846 - $49,655
-182 Reduced 52.91%
162 $28,000
Q3 2020

Nov 10, 2020

BUY
$185.27 - $238.73 $43,538 - $56,101
235 Added 215.6%
344 $67,000
Q2 2020

Aug 13, 2020

BUY
$153.32 - $191.72 $4,599 - $5,751
30 Added 37.97%
109 $19,000
Q1 2020

May 12, 2020

SELL
$124.34 - $193.76 $248 - $387
-2 Reduced 2.47%
79 $13,000
Q4 2019

Feb 11, 2020

BUY
$134.81 - $177.8 $10,919 - $14,401
81 New
81 $13,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.09B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.